
First-of-Its-Kind Breast Cancer Research Study Explores the Impact of Weight Loss Drugs on Recurrence
Newswise — A breast cancer research study now open at Baylor University Medical Center in Dallas is believed to be the first of its kind to explore the ability of new weight loss GIP/GLP-1 receptor agonists to combat breast cancer recurrence in …